CL
FLNA

CSS LLC’s Filana Therapeutics FLNA Stock Holding History

CSS LLC’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$8K – 1080
2022
Q3 		$8K Buy
+200
New +$5.4K ﹤0.01% 979
2022
Q1 		– Sell
-34,100
Closed -$1.49M – 1302
2021
Q4 		$1.49M Buy
34,100
+27,500
+417% +$1.44M 0.05% 320
2021
Q3 		$410K Sell
6,600
-15,500
-70% -$1.29M 0.02% 700
2021
Q2 		$1.89M Buy
+22,100
New +$1.18M 0.08% 267

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CSS LLC's FLNA Position: Q1 2022 in Review

CSS LLC sold out of Filana Therapeutics (FLNA) in Q1 2022, closing a stake of 8,381 shares — an estimated $355K sold.

CSS LLC first reported a position in FLNA in Q2 2021 and held it in 3 quarters. The position peaked at $1.6M in Q3 2021. 163 funds tracked by Wall St. Rank hold FLNA as of Q1 2022.

  • CSS LLC reported no remaining Filana Therapeutics position as of Q1 2022 after selling out during the quarter.
  • CSS LLC sold 8,381 Filana Therapeutics shares in Q1 2022, an estimated $355K.
  • CSS LLC first reported a position in Filana Therapeutics in Q2 2021 and held it in 3 quarters.
  • CSS LLC's Filana Therapeutics position peaked at $1.6M in Q3 2021.
  • 163 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2022.

Based on CSS LLC's 13F filing for Q1 2022, filed 16 May 2022.